Download presentation
Presentation is loading. Please wait.
Published byJohnathan Simmons Modified over 9 years ago
1
DIVISION OF REPRODUCTIVE AND UROLOGIC PRODUCTS Extended Dosing Regimens Gerald Willett MD
2
2 Altering the 7-Day Placebo Window 21 Days Active Combined7 Days Placebo 2 Days Placebo 5 Days of 10ug EE 3 Days Active Combined 4 Days Placebo
3
3 Extending Active Combined Pills > 28 days 217 7 7 7 84 Days Active Combined7 7 (Placebo) (10 ug EE)
4
4 Extended Regimens Compared to the traditional 21/7 products: these extended regimen products have been approved on similar safety and efficacy criteria depending on dosage, may have a higher amount of hormonal exposure on a monthly basis
5
5 Cycle Control – 84 Day Active Regimens Proposed Benefits DemonstratedBenefits Demonstrated Drawbacks ↓ menstrual period frequency frequency ↓ overall bleeding ↓ scheduled bleeding episodes bleeding episodes ↑ unscheduled bleeding/ spotting bleeding/ spotting episodes episodes no “missed period” signal for pregnancy
6
6 Effects of Extended Regimens Other Menstrual–Related Symptoms Proposed Benefits Demonstrated Benefit ↓ PMDD / PMS ↓ Dysmenorrhea ↓ Migraines ↓ Epilepsy Secondary indication for Secondary indication for premenstrual dysphoric premenstrual dysphoric disorder (PMDD) disorder (PMDD)
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.